Related Experiment Videos
Nestin expression in ganglioglioma
Neil Duggal1, Robert R Hammond
1Department of Clinical Neurological Sciences, Division of Neurosurgery, London, Ontario N6A 5C1, Canada.
Experimental Neurology
|March 1, 2002
Summary
Gangliogliomas contain nestin-positive neuronal cells, suggesting a stem cell origin. This finding offers new insights into the pathogenesis of gangliogliomas and associated epilepsy.
Area of Science:
- Neuroscience
- Oncology
- Pathology
Background:
- Gangliogliomas are rare tumors with debated origins, possibly stemming from dysplastic tissue or multipotent stem cells.
- Understanding the cellular lineage is crucial for elucidating ganglioglioma pathogenesis and associated epilepsy.
Purpose of the Study:
- To investigate the expression of nestin, a stem cell marker, in gangliogliomas.
- To correlate nestin expression with other cellular markers and clinical features.
Main Methods:
- Histological review of 18 ganglioglioma cases.
- Immunohistochemistry for nestin, MAP2, neurofilament, and GFAP.
- Confocal scanning laser microscopy for detailed cellular analysis.
Main Results:
- All 18 gangliogliomas exhibited abundant nestin- and MAP2-positive neuronal cells.
- GFAP staining was observed in astrocytes, not neuronal cells.
- Nestin and MAP2 showed colocalization in some neuronal cells.
Conclusions:
- Gangliogliomas contain neuronal cells expressing nestin, a persistent stem cell marker.
- These findings support the hypothesis of a stem cell origin for gangliogliomas.
- Further research into nestin-positive cells may illuminate ganglioglioma pathogenesis and epilepsy.